Splenectomy in early chronic myeloid leukaemia: preliminary report on 37 cases.
D000293:Adolescent; D000328:Adult; D001772:Blood Cell Count; D001792:Blood Platelets; D003561:Cytarabine / Q000627:therapeutic use; D003643:Death; D004359:Drug Therapy, Combination; D006410:Hematopoiesis; D006465:Hemoperitoneum / Q000209:etiology; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007951:Leukemia, Myeloid / Q000601:surgery*; D007958:Leukocyte Count; D008875:Middle Aged; D009929:Organ Size; D010996:Pleural Effusion / Q000209:etiology; D011014:Pneumonia / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D011704:Pyelonephritis / Q000209:etiology; D013154:Spleen / Q000473:pathology; D013156:Splenectomy / Q000009:adverse effects; D013369:Subphrenic Abscess / Q000209:etiology; D013922:Thrombocytosis / Q000209:etiology; D013924:Thrombophlebitis / Q000209:etiology; D014750:Vincristine / Q000627:therapeutic use
D003561:Cytarabine; D014750:Vincristine; D011241:Prednisone; D006918:Hydroxyurea